Related Experiment Videos
Complement fixation and neutralization RS antibodies in maternal and neonatal sera
The Journal of Hygiene
|June 1, 1977
Summary
Maternal and cord blood showed higher levels of respiratory syncytial virus (RSV) complement fixation antibodies in cord blood. However, microneutralization tests revealed no significant differences in RSV antibody levels between maternal and cord sera.
Area of Science:
- Immunology
- Virology
- Maternal-fetal medicine
Background:
- Respiratory Syncytial Virus (RSV) is a major cause of respiratory illness in infants and young children.
- Understanding transplacental transfer of RSV antibodies is crucial for assessing infant immunity.
- Complement fixation and microneutralization are key assays for measuring antibody responses.
Purpose of the Study:
- To compare levels of RSV-specific antibodies in paired maternal and cord blood sera.
- To evaluate the effectiveness of different antibody assays in reflecting maternal-fetal antibody transfer.
Main Methods:
- Collected 200 paired maternal and cord blood sera samples.
- Assessed RSV-specific antibodies using complement fixation tests.
- Performed microneutralization assays on a subset of samples for comparative analysis.
Main Results:
- Geometric mean titers (GMTs) of complement fixation antibodies were significantly higher in cord sera compared to maternal sera.
- This difference in complement fixation antibody levels was independent of the specific RSV strain used.
- Microneutralization tests, however, showed no significant difference in GMTs between maternal and cord sera.
Conclusions:
- Complement fixation assay suggests enhanced RSV antibody levels in neonates compared to their mothers.
- Microneutralization assay indicates similar levels of neutralizing RSV antibodies between mothers and newborns.
- Discrepancies between assays highlight the importance of assay selection in evaluating maternal-fetal antibody transfer for RSV.